巨细胞动脉炎患者胸主动脉并发症风险增加:一项全国性人群队列研究
该研究基于丹麦全国健康登记数据,纳入1996至2018年间9908例巨细胞动脉炎(GCA)患者及98204名匹配的普通人群参照者,评估主动脉瘤(AA)、主动脉夹层(AD)及外周动脉疾病(PAD)风险。结果显示GCA患者胸主动脉瘤和主动脉夹层的15年相对风险显著升高,而腹主动脉瘤风险未见增加。
要点
- GCA患者15年胸主动脉瘤风险显著升高,RR为11.2(95%CI 7.41-16.9)。
- GCA患者15年主动脉夹层风险显著升高,RR为6.86(95%CI 4.13-11.4)。
- GCA患者腹主动脉瘤风险未显著增加,RR为1.04(95%CI 0.83-1.32)。
核心结论
- GCA患者发生胸主动脉瘤和主动脉夹层的风险显著增加,但腹主动脉瘤风险未见增加。
研究设计与样本
- 全国性人群队列研究,利用丹麦全国健康登记数据,纳入1996至2018年间年龄≥50岁、领取三次及以上泼尼松龙处方的所有新发GCA患者,并以年龄、性别和日历时间1:10匹配普通人群参照者。
主要发现
- GCA队列15年胸主动脉瘤累积发病比例为1.9%(95%CI 1.5-2.2),腹主动脉瘤为1.8%(95%CI 1.4-2.2),主动脉夹层为1.0%(95%CI 0.7-1.2),PAD为4.8%(95%CI 4.2-5.3)。
- 与参照者相比,15年RR:胸主动脉瘤为11.2(95%CI 7.41-16.9),主动脉夹层为6.86(95%CI 4.13-11.4),腹主动脉瘤为1.04(95%CI 0.83-1.32),PAD为1.53(95%CI 1.35-1.74)。
- GCA患者中,女性、年龄低于70岁及颞动脉检查阳性为发生胸主动脉瘤的危险因素。
- 胸主动脉瘤的中位时间为7.5年(四分位距4.4-11.2),5年、10年和15年需筛查人数分别为250(95%CI 167-333)、91(95%CI 71-111)和53(95%CI 45-67)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the risk of aortic aneurysms (AA), aortic dissections (AD) and peripheral arterial disease (PAD) among patients with GCA. METHODS: In this nationwide, population-based cohort study using Danish national health registries, we identified all incident GCA patients ≥50 years between 1996 and 2018 who redeemed three or more prescriptions for prednisolone. Index date was the date of redeeming the third prednisolone prescription. Case definition robustness was checked through sensitivity analysis. We included general population referents matched 1:10 by age, sex and calendar time. Using a pseudo-observation approach, we calculated 5-, 10- and 15-year cumulative incidence proportions (CIP) and relative risks (RR) of AA, AD and PAD with death as a competing risk. RESULTS: We included 9908 GCA patients and 98 204 referents. The 15-year CIP of thoracic AA, abdominal AA, AD and PAD in the GCA cohort were 1.9% (95% CI 1.5, 2.2), 1.8% (1.4-2.2), 1.0% (0.7-1.2) and 4.8% (4.2-5.3). Compared with the referents, the 15-year RR were 11.2 (7.41-16.9) for thoracic AA, 6.86 (4.13-11.4) for AD, 1.04 (0.83-1.32) for abdominal AA and 1.53 (1.35-1.74) for PAD. Among GCA patients, female sex, age below 70 years and positive temporal artery findings were risk factors for developing thoracic AA. The median time to thoracic AA was 7.5 years (interquartile range 4.4-11.2) with a number needed to be screened of 250 (167-333), 91 (71-111) and 53 (45-67) after 5, 10 and 15 years. CONCLUSION: Patients with GCA have a markedly increased risk of developing thoracic AA and AD, but no increased risk of abdominal AA.
引用
- Therkildsen P, de Thurah A, Nielsen BD, et al. Increased risk of thoracic aortic complications among patients with giant cell arteritis: a nationwide, population-based cohort study. Rheumatology (Oxford). 2022. PMID: 34918058. doi:10.1093/rheumatology/keab871
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。